GLAXOSMITH - Glaxo Smithkline Consumer
Manufacturing, Marketing and Distribution of Pharmaceutical, Oral Care and Nutritional Products
Glaxo Smithkline Consumer is listed on the Nigerian Stock Exchange (NGX). Glaxo Smithkline Consumer is traded on the NGX under the ticker symbol “GLAXOSMITH”. The International Securities Identification Number (ISIN) of NGX:GLAXOSMITH is NGGLAXOSMTH8. Glaxo Smithkline Consumer is currently the 74th most valuable stock on the NGX with a market capitalization of NGN 7.12 billion, which makes about 0.027% of the Nigerian Stock Exchange equity market.
|Last Trading Results|
|Day’s Low Price|
|Day’s High Price|
|Number of Deals||18|
|Growth & Valuation|
|Earnings Per Share|
|Dividend Per Share|
GLAXOSMITH Stock Market Performance
The current share price of Glaxo Smithkline Consumer (GLAXOSMITH) is NGN 5.95. GLAXOSMITH closed its last trading day (Friday, August 12, 2022) at 5.95 NGN per share on the Nigerian Stock Exchange (NGX).
Glaxo Smithkline Consumer is the 59th most traded stock on the Nigerian Stock Exchange over the past three months (May 13 - Aug 12, 2022). GLAXOSMITH has traded a total volume of 32.7 million shares—in 2,087 deals—valued at NGN 222 million over the period, with an average of 518,535 traded shares per session. A volume high of 4.41 million was achieved on May 17th, and a low of 6,729 on July 20th, for the same period. The table below details the last 10 trading days of activity of Glaxo Smithkline Consumer on the Nigerian Stock Exchange.
Profile of Glaxo Smithkline Consumer
Glaxo Smithkline Consumer operates in the Health Care sector.
Factsheet of Glaxo Smithkline Consumer
- Health Care
- 1, Industrial Avenue, Ilupeju Lagos
GLAXOSMITH Industrial Market Competitors
Glaxo Smithkline Consumer, issuers of the GLAXOSMITH stock on the Nigerian Stock Exchange, have six market competitors who are also engaged in the Health Care sector. The table below presents an overview of their market standing.
|MAYBAKER||May & Baker Nigeria||6.73B||3.90||-2.99%|
|NEIMETH||Neimeth International Pharma||2.66B||1.40||-20%|